FDA to review Neos' ADHD therapy

Neos Therapeutics Inc. (Lincolnshire, Ill.) said FDA accepted for review an NDA for NT0202 to treat ADHD. The PDUFA date is Oct. 28. The NDA was submitted under section 505(b)(2) of the Food, Drug and...